VEGFR1/R2/R3 Antibody (FLT1/1663) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14285F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # FLT1/1663
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human VEGFR1/R2/R3 protein (Uniprot: P17948)
Reactivity Notes
0
Localization
Cell surface
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for VEGFR1/R2/R3 Antibody (FLT1/1663) [FITC]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: VEGFR1/R2/R3
Long Name
Vascular Endothelial Growth Factor Receptor 1
Alternate Names
FLT;FLT1;FLT-1;Receptor protein-tyrosine kinase;Vascular endothelial growth factor receptor 1;VEGFR1;VEGFR-1
Gene Symbol
FLT1
Additional VEGFR1/R2/R3 Products
Product Documents for VEGFR1/R2/R3 Antibody (FLT1/1663) [FITC]
Product Specific Notices for VEGFR1/R2/R3 Antibody (FLT1/1663) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...